BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6314036)

  • 1. [Angiotensin-converting enzyme activity during cytostatic therapy in patients with primary inoperable bronchial carcinoma].
    Heck I; Niederle N
    Klin Wochenschr; 1983 Sep; 61(18):923-7. PubMed ID: 6314036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polychemotherapy in inoperable bronchial carcinoma].
    Schmidt CG
    Strahlentherapie; 1984 Feb; 160(2):71-6. PubMed ID: 6328699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma angiotensin-converting enzyme activity in patients with bronchial carcinoma.
    Roulston JE; Galloway PJ; Douglas G
    Br J Dis Chest; 1986 Jul; 80(3):229-34. PubMed ID: 3024690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens.
    Nõu E; Brodin O; Bergh J
    Cancer; 1988 Sep; 62(6):1079-90. PubMed ID: 2457422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
    Taytard A; Chomy P; Courty G; Gachie JP; Roquain J
    Rev Fr Mal Respir; 1980; 8(3):225-32. PubMed ID: 6314444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
    Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
    J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
    Valdivieso M; Cabanillas F; Keating M; Barkley HT; Murphy WK; Burgess MA; Frazier H; Chen T; Bodey GP
    Am J Med; 1984 Mar; 76(3):405-12. PubMed ID: 6322584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy.
    Brower M; Ihde DC; Johnston-Early A; Bunn PA; Cohen MH; Carney DN; Makuch RW; Matthews MJ; Radice PA; Minna JD
    Am J Med; 1983 Dec; 75(6):993-1000. PubMed ID: 6316784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic results in small-cell bronchial carcinoma after ACO II chemotherapy and adjuvant radiation].
    Leipner N; Harder T; Hövelmann B; Schüller H; Hartlapp JH; Boldt I
    Strahlenther Onkol; 1987 Oct; 163(10):637-42. PubMed ID: 2823403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
    Dangubić V; Vukov N; Mrda V; Spasić D; Sikimić S; Popvić D; Perunović O; Bjelić R
    Zb Vojnomed Akad; 1983; 25():40-4. PubMed ID: 6099941
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC Lung Cancer Working Party (Belgium).
    Klastersky J; Sculier JP; Dumont JP; Becquart D; Vandermoten G; Rocmans P; Michel J; Longeval E; Dalesio O
    Cancer; 1985 Jul; 56(1):71-5. PubMed ID: 2988738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adriamycin, cyclophosphamide and vincristine (ACO) in small cell bronchial cancer. Course of the disease and long-term follow-up].
    Seeber S; Niederle N; Schilcher RB; Schmidt CG
    Onkologie; 1980 Feb; 3(1):5-11. PubMed ID: 6258116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus.
    Hodson DI; Malaker K; Meikle AL; Levitt M
    Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1941-5. PubMed ID: 6092307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Occurrence of an epidermoid bronchial carcinoma 8 years after a small cell carcinoma treated with only 3 courses of chemotherapy].
    Molimard M; Lebeau B
    Rev Med Interne; 1992 Nov; 13(6):441-2. PubMed ID: 1285357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of palliative chemotherapy in advanced small cell bronchial carcinoma].
    Fritze D; Harjung H; Katz R; Kober B
    Dtsch Med Wochenschr; 1988 Oct; 113(43):1663-8. PubMed ID: 2460301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of the non-small cell bronchogenic carcinoma].
    Dimitriadis K; Boutis L; Tavantzis J; Mouratidou D; Bouchoris N; Koukourikos S; Hatzigogos K; Safarini S
    Onkologie; 1983 Feb; 6(1):8-10. PubMed ID: 6189039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for metastatic Merkel cell carcinoma.
    George TK; di Sant'agnese PA; Bennett JM
    Cancer; 1985 Sep; 56(5):1034-8. PubMed ID: 2990663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.